Assembly Biosciences Inc. (ASMB) Financial Statements (2024 and earlier)

Company Profile

Business Address TWO TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments130,24791,610146,627216,413274,043218,080
Cash and cash equivalents19,84152,41845,62759,44446,73241,471
Short-term investments110,40639,192101,000156,969227,311176,609
Receivables439443361,2303,3742,430
Other undisclosed current assets3,4974,4137,2416,8505,3631,992
Total current assets:133,78796,967154,204224,493282,780222,502
Noncurrent Assets
Operating lease, right-of-use asset2,3393,1956,0429,13111,975
Property, plant and equipment3857431,1391,6001,830557
Long-term investments and receivables   27,972   
Long-term investments   27,972   
Intangible assets, net (including goodwill)    41,63841,63841,638
Goodwill    12,63812,63812,638
Intangible assets, net (excluding goodwill)    29,00029,00029,000
Other noncurrent assets3128891,7036,3921,6843,348
Total noncurrent assets:3,0364,82736,85658,76157,12745,543
TOTAL ASSETS:136,823101,794191,060283,254339,907268,045
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,2059,8109,52216,58510,0179,679
Accounts payable4612,4932,6594,5981,731 
Accrued liabilities5,7447,3176,86311,9878,2869,679
Deferred revenue30,915   6,411
Debt     3,186 
Deferred tax liabilities3,252
Other undisclosed current liabilities2,1056,4866,5517,8484,8265,541
Total current liabilities:39,22516,29616,07324,43324,44018,472
Noncurrent Liabilities
Long-term debt and lease obligation:   3,3256,7259,082 
Liabilities, other than long-term debt56,5012,8342,73311,51833,168108
Deferred revenue55,3792,7332,7338,98730,637
Deferred rent credit      108
Deferred income tax liabilities    2,5312,531
Operating lease, liability1,1221013,3256,7259,082
Other undisclosed noncurrent liabilities      38,812
Total noncurrent liabilities:56,5012,8346,05818,24342,25038,920
Total liabilities:95,72619,13022,13142,67666,69057,392
Equity
Equity, attributable to parent41,09782,664168,929240,578273,217210,653
Common stock54948343225
Additional paid in capital826,921807,938800,728742,387712,807552,762
Accumulated other comprehensive loss(81)(803)(419)(270)(201)(347)
Accumulated deficit(785,748)(724,520)(631,428)(501,573)(439,421)(341,787)
Total equity:41,09782,664168,929240,578273,217210,653
TOTAL LIABILITIES AND EQUITY:136,823101,794191,060283,254339,907268,045

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues7,1631536,25479,10515,96314,804
Sublease income 102153142  
Gross profit:7,1631536,25479,10515,96314,804
Operating expenses(71,809)(94,114)(138,942)(143,881)(118,676)(107,539)
Other undisclosed operating income (loss) (153)    
Operating loss:(64,646)(94,114)(132,688)(64,776)(102,713)(92,735)
Nonoperating income3,4511,0223022,6244,3053,083
Loss from continuing operations before income taxes:(61,195)(93,092)(132,386)(62,152)(98,408)(89,652)
Income tax expense (benefit) (33) 2,531 774(1,099)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(61,228)(93,092)(129,855)(62,152)(97,634)(90,751)
Loss before gain (loss) on sale of properties:(129,855)(62,152)(97,634)(90,751)
Net loss available to common stockholders, diluted:(61,228)(93,092)(129,855)(62,152)(97,634)(90,751)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(61,228)(93,092)(129,855)(62,152)(97,634)(90,751)
Comprehensive loss:(61,228)(93,092)(129,855)(62,152)(97,634)(90,751)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent722(384)(149)(69)14645
Comprehensive loss, net of tax, attributable to parent:(60,506)(93,476)(130,004)(62,221)(97,488)(90,706)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: